StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical ...

The Danish pharma group is pledging $285 million in upfront and milestone payments for the lead GLP-1 asset in the ...

Additionally, wear-and-tear arthritis is a leading cause of hip pain in women. Women are more likely to have hip pain as a ...

Total gross proceeds from upsized initial public offering and Series C financing were approximately $251.2 million Last ...

Kidney problems, particularly Chronic Kidney Disease (CKD), increase the risk of strokes and heart attacks. Patients with metabolic syndrome (MetS) and CKD are more prone to strokes, especially those ...